Pyrrolidine dithiocarbamate partially attenuates the effect of phosphatidylethanolamine-binding protein 4 deletion on liver fibrosis via the nuclear factor-κappa B signaling pathway. The gene discussed is PEBP4; the disease is Hepatic fibrosis.